Aktie A3EZYL CM HOSPITALAR S/A
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen CM Hospitalar S/A

Aktien

A3EZYL

BRVVEOACNOR0

VVEO3

Verzögert Sao Paulo
Andere Börsenplätze
 16:02:33 29.04.2024 		% 5 Tage % 1. Jan.
5,39 BRL -17,71 % Intraday Chart für CM Hospitalar S/A -17,71 % -61,36 %
26.03. CM Hospitalar S/A meldet Ergebnis für das Geschäftsjahr bis zum 31. Dezember 2023 CI
26.03. CM Hospitalar S/A meldet Ergebnis für das vierte Quartal bis zum 31. Dezember 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2023
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CM Hospitalar S/A(BOVESPA:VVEO3) added to Brazil Small Cap Index
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2023
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2022
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2022
CM Hospitalar S/A acquired remaining stake in Far.me.
CM Hospitalar S/A Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CM Hospitalar S/A agreed to acquire Neve Industria e Comercio de Produtos Cirurgicos and Nutrifica Comercio de Nutricao Enteral e Parenteral for BRL 110 million.
CM Hospitalar S/A Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Brazil's Viveo sees $23 mln EBITDA growth after multiple acquisitions
CM Hospitalar S/A entered into a definite agreement to acquire Pro-Formula Quimioterapica Ltda from Vinci Impacto e Retorno IV, managed by Vinci Capital Gestora de Recursos Ltda. and others.
CM Hospitalar S/A Reports Earnings Results for the First Quarter Ended March 31, 2022
CM Hospitalar S/A acquired Boxifarma.
CM Hospitalar S/A Reports Earnings Results for the Full Year Ended December 31, 2021
CM Hospitalar S/A Reports Earnings Results for the Fourth Quarter Ended December 31, 2021
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3EZYL Aktie
  4. Nachrichten CM Hospitalar S/A
  5. Andere Sprachen